ASO Author Reflections: The Survival Advantage Persists: Benefit of Adjuvant Chemotherapy in Resected, Stage IA Pancreatic Cancer

被引：0
|
作者：
Turner, Kevin M. [1 ]
Patel, Sameer H. [2 ]
机构：
[1] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH USA
[2] Univ Cincinnati, Dept Surg, Div Surg Oncol, Coll Med, Cincinnati, OH 45221 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2022年 / 29卷 / 07期
关键词：
D O I：
10.1245/s10434-022-11650-w
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：4620 / 4621
页数：2
相关论文
共 50 条
  • [1] ASO Author Reflections: The Survival Advantage Persists: Benefit of Adjuvant Chemotherapy in Resected, Stage IA Pancreatic Cancer
    Kevin M. Turner
    Sameer H. Patel
    Annals of Surgical Oncology, 2022, 29 : 4620 - 4621
  • [2] ASO Visual Abstract: Is There a Benefit to Adjuvant Chemotherapy in Resected, Early-Stage Pancreatic Ductal Adenocarcinoma?
    Kevin M. Turner
    Aaron M. Delman
    Allison M. Ammann
    Davendra Sohal
    Olugbenga Olowokure
    Kyuran A. Choe
    Milton T. Smith
    Jordan R. Kharofa
    Syed A. Ahmad
    Gregory C. Wilson
    Sameer H. Patel
    Annals of Surgical Oncology, 2022, 29 : 4622 - 4623
  • [3] ASO Visual Abstract: Is There a Benefit to Adjuvant Chemotherapy in Resected, Early-Stage Pancreatic Ductal Adenocarcinoma?
    Turner, Kevin M.
    Delman, Aaron M.
    Ammann, Allison M.
    Sohal, Davendra
    Olowokure, Olugbenga
    Choe, Kyuran A.
    Smith, Milton T.
    Kharofa, Jordan R.
    Ahmad, Syed A.
    Wilson, Gregory C.
    Patel, Sameer H.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (07) : 4622 - 4623
  • [4] ASO Author Reflections: Does Adjuvant Therapy Confer a Survival Benefit in Patients Receiving Neoadjuvant Chemotherapy for Pancreatic Cancer? A CA19-9 Analysis
    Liu, Hao
    Zureikat, Amer
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (10) : 3961 - 3962
  • [5] ASO Author Reflections: Does Adjuvant Therapy Confer a Survival Benefit in Patients Receiving Neoadjuvant Chemotherapy for Pancreatic Cancer? A CA19-9 Analysis
    Hao Liu
    Amer Zureikat
    Annals of Surgical Oncology, 2020, 27 : 3961 - 3962
  • [6] Utilization and benefit of adjuvant chemotherapy for patients with resected pancreatic cancer
    Nguyen, N. Q.
    Johns, A.
    Chang, D.
    Merrett, N. D.
    Biankin, A. V.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A272 - A272
  • [7] Utilization and Benefit of Adjuvant Chemotherapy for Patients with Resected Pancreatic Cancer
    Nguyen, Nam Q.
    Johns, Amber L.
    Chang, David
    Merrett, Neil
    Biankin, Andrew V.
    GASTROENTEROLOGY, 2009, 136 (05) : A315 - A315
  • [8] ASO Author Reflections: Survival Benefit of Adjuvant Chemoradiotherapy for Gallbladder Cancer: The Role of Radiation Therapy Revisited
    Kim, Byoung Hyuck
    Chie, Eui Kyu
    Kim, Kyubo
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 788 - 789
  • [9] ASO Author Reflections: Survival Benefit of Adjuvant Chemoradiotherapy for Gallbladder Cancer: The Role of Radiation Therapy Revisited
    Byoung Hyuck Kim
    Eui Kyu Chie
    Kyubo Kim
    Annals of Surgical Oncology, 2018, 25 : 788 - 789
  • [10] ASO Author Reflections: Is There an Extra Benefit of Adding Neoadjuvant Radiotherapy to Chemotherapy in Patients with (Borderline) Resectable Pancreatic Cancer?
    Yun, Won-Gun
    Jang, Jin-Young
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (04) : 2859 - 2860
12345